General Xenobiochemistry Metabolism of megestrol acetate in vitro and the role of oxidative metabolites
Larry House, Michael J. Seminerio, Snezana Mirkov, Jacqueline Ramirez, Maxwell Skor, Joseph R. Sachleben, Masis Isikbay, Hari Singhal, Geoffrey L. Greene, Donald Vander Griend, Suzanne D. Conzen & Mark J. Ratain
Pages: 973-983 | DOI: 10.1080/00498254.2017.1386335
Changes in CYP2D enzyme activity following induction of type 2 diabetes, and administration of cinnamon and metformin: an experimental animal study
Ali Taheri, Hoda Lavasani, Sara Kasirzadeh, Behjat Sheikholeslami, Yalda H. Ardakani & Mohammad-Reza Rouini
Pages: 984-989 | DOI: 10.1080/00498254.2017.1390626
Stereoselective in vitro metabolism of rhynchophylline and isorhynchophylline epimers of Uncaria rhynchophylla in rat liver microsomes
Xin Wang, Zhou Qiao, Jia Liu, Mei Zheng, Wenyuan Liu & Chunyong Wu
Pages: 990-998 | DOI: 10.1080/00498254.2017.1390627
The potent mechanism-based inactivation of CYP2D6 and CYP3A4 with fusidic acid in in vivo bioaccumulation
Xiu-Xian Lin, Guang-Hui Lian, Ying Xu, Qing Zhao, Jian Xiao, Shi-Fang Peng, Mei-Fang Xiao, Dong-Sheng Ouyang, Zhi-Rong Tan, Yi-Cheng Wang, Jing-Bo Peng, Wei Zhang & Yao Chen
Pages: 999-1005 | DOI: 10.1080/00498254.2017.1390628
Clinical Pharmacokinetics and Metabolism Mass balance and metabolism of Z-215, a novel proton pump inhibitor, in healthy volunteers
Ryoko Toda, Tomoharu Miyagawa, Yuka Masuda, Yusuke Hoshino, Kazuyoshi Yoshii, Masamichi Hirayama, Minaka Shibuya & Yoshihiro Kawabata
Pages: 1006-1020 | DOI: 10.1080/00498254.2017.1390625
Animal Pharmacokinetics and Metabolism Characterizing the in vitro species differences in N-glucuronidation of a potent pan-PIM inhibitor GNE-924 containing a 3,5-substituted 6-azaindazole
Molly Lin, Justin Ly, Ryan Takahashi, John Chen, Alan Deese, Sarah J. Robinson, Aleksandr Kolesnikov, Susan Wong, Xiaojing Wang & Jae H. Chang
Pages: 1021-1027 | DOI: 10.1080/00498254.2017.1373312
Quercetin nanoparticles alter pharmacokinetics of bromocriptine, reflecting its enhanced inhibitory action on liver and intestinal CYP 3A enzymes in rats
Suresh Palle & Prasad Neerati
Pages: 1028-1036 | DOI: 10.1080/00498254.2017.1390277
Xenobiotic Transporters In vitro studies with two human organic anion transporters: OAT2 and OAT7
Sumathy Mathialagan, Chester Costales, Laurie Tylaska, Emi Kimoto, Anna Vildhede, Jillian Johnson, Nathaniel Johnson, Takami Sarashina, Kenta Hashizume, Caleb D. Isringhausen, Lydia M. M. Vermeer, Andrea R. Wolff & A. David Rodrigues
Pages: 1037-1049 | DOI: 10.1080/00498254.2017.1384595
MicroRNA-655-3p regulates Echinacea purpurea mediated activation of ABCG2
Charles Awortwe, Meike Kaehler, Bernd Rosenkranz, Ingolf Cascorbi & Henrike Bruckmueller
Pages: 1050-1058 | DOI: 10.1080/00498254.2017.1390624
Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1
Hiroyoshi Koide, Masayuki Tsujimoto, Ai Takeuchi, Miyu Tanaka, Yoko Ikegami, Mayu Tagami, Syoko Abe, Miki Hashimoto, Tetsuya Minegaki & Kohshi Nishiguchi
Pages: 1059-1071 | DOI: 10.1080/00498254.2017.1393582
Pharmacogenetics Association with polymorphic marmoset cytochrome P450 2C19 of in vivo hepatic clearances of chirally separated R-omeprazole and S-warfarin using individual marmoset physiologically based pharmacokinetic models
Takashi Kusama, Akiko Toda, Makiko Shimizu, Shotaro Uehara, Takashi Inoue, Yasuhiro Uno, Masahiro Utoh, Erika Sasaki & Hiroshi Yamazaki
Pages: 1072-1077 | DOI: 10.1080/00498254.2017.1393121
Corrigendum Correction to: Koide et al., Substrate-dependent effects of molecular-targeted anticancer agents on activity of organic anion transporting polypeptide 1B1
Pages: x-x | DOI: 10.1080/00498254.2018.1434920
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου